Description
Retatrutide is a triple-receptor agonist (GIP, GLP-1, and glucagon) studied in metabolic and body-composition laboratory research models. Research use only. Not for human consumption.
Retatrutide 20 mg
$82.00
Triple-agonist research peptide, 20 mg. 99%+ purity, third-party tested.
Reviews
There are no reviews yet.